Advanced Biomed Inc. Common Stock
ADVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -12.1% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $2,110 | $1 | $0 |
| SG&A Expenses | $0 | $2,110 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,110 | -$1 | -$0 |
| Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | -228.5% | – | – |
| Other Income/Exp. Net | $0 | $0 | -$1 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | -132.2% | – | – |
| EPS | -0.001 | -0.001 | -0.069 | -0.045 |
| % Growth | 45.5% | 98.4% | -52% | – |
| EPS Diluted | -0.001 | -0.001 | -0.069 | -0.045 |
| Weighted Avg Shares Out | 22 | 22 | 20 | 20 |
| Weighted Avg Shares Out Dil | 22 | 22 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | -120.1% | – | – |